| Code | Description | Claims | Beneficiaries | Total Paid |
| J0178 |
Injection, aflibercept, 1 mg |
511 |
427 |
$454K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
4,928 |
4,213 |
$195K |
| 92134 |
|
6,963 |
6,317 |
$126K |
| J9035 |
Injection, bevacizumab, 10 mg |
2,239 |
1,960 |
$103K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
101 |
89 |
$46K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
989 |
954 |
$40K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
806 |
789 |
$34K |
| J3590 |
Unclassified biologics |
198 |
177 |
$14K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
260 |
254 |
$14K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
156 |
156 |
$13K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
203 |
200 |
$12K |
| 92235 |
|
115 |
111 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
86 |
81 |
$5K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
30 |
30 |
$3K |